ciprofloxacin has been researched along with Bleb in 14 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The elimination half-life from blister fluid was 4." | 2.67 | The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po. ( Andrews, JM; Catchpole, C; Wise, R; Woodcock, J, 1994) |
| "Serum, blister fluid, and paper disk samples were analyzed by large-plate microbiologic assay." | 2.67 | Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study. ( Lubowski, TJ; Nightingale, C; Quintiliani, R; Sweeney, K; Zhi, J, 1992) |
| " The mean terminal serum half-life was 4." | 1.27 | Pharmacokinetics of intravenously administered ciprofloxacin. ( Dent, J; Lockley, RM; Webberly, M; Wise, R, 1984) |
| " The serum elimination half-life was 3." | 1.27 | Pharmacokinetics and tissue penetration of ciprofloxacin. ( Crump, B; Dent, J; Wise, R, 1983) |
| "The pharmacokinetics and the suction-induced blister fluid penetration of ciprofloxacin were compared after a single dose (500 mg) and after multiple dosing (500 mg q8h for 13 doses)." | 1.27 | Tissue penetration of ciprofloxacin after single and multiple doses. ( Bergeron, MG; LeBel, M; Vallée, F, 1986) |
| " The elimination half-life in serum was 11." | 1.27 | Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone. ( Ashby, J; Griggs, DJ; Kirkpatrick, B; Wise, R, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mollica, AJ | 2 |
| Grant, E | 1 |
| Malik, A | 1 |
| Claydon, M | 1 |
| Cowart, DW | 1 |
| Moradi, BN | 1 |
| Arora, NS | 1 |
| Mazzarolo, SS | 1 |
| Elzir, L | 1 |
| Saliba, I | 1 |
| Wise, R | 5 |
| Lockley, RM | 1 |
| Webberly, M | 1 |
| Dent, J | 2 |
| Crump, B | 1 |
| Catchpole, C | 1 |
| Andrews, JM | 1 |
| Woodcock, J | 1 |
| Kawada, A | 1 |
| Hiruma, M | 1 |
| Noguchi, H | 1 |
| Banba, K | 1 |
| Ishibashi, A | 1 |
| Banba, H | 1 |
| Marshall, J | 1 |
| Lubowski, TJ | 1 |
| Nightingale, C | 1 |
| Sweeney, K | 1 |
| Quintiliani, R | 1 |
| Zhi, J | 1 |
| Limberg, J | 1 |
| LeBel, M | 2 |
| Derendorf, H | 1 |
| Vallée, F | 1 |
| Bergeron, MG | 1 |
| Kirkpatrick, B | 1 |
| Ashby, J | 1 |
| Griggs, DJ | 1 |
| Donovan, IA | 1 |
| Bergan, T | 1 |
| Engeset, A | 1 |
| Olszewski, W | 1 |
| Ostby, N | 1 |
| Solberg, R | 1 |
2 trials available for ciprofloxacin and Bleb
| Article | Year |
|---|---|
The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.
Topics: Administration, Oral; Adult; Biological Assay; Biological Availability; Blister; Chromatography, Hig | 1994 |
Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
Topics: Administration, Oral; Adult; Blister; Body Fluids; Ciprofloxacin; Female; Fleroxacin; Humans; Male; | 1992 |
12 other studies available for ciprofloxacin and Bleb
| Article | Year |
|---|---|
Ciprofloxacin-Induced Bullae of the Lower Extremity: A Case of a Fixed Drug Reaction.
Topics: Anti-Bacterial Agents; Blister; Ciprofloxacin; Drug-Related Side Effects and Adverse Reactions; Foot | 2019 |
A 50-year-old man with blistering skin lesions on both feet.
Topics: Blister; Ciprofloxacin; Disease Progression; Follow-Up Studies; Hawaii; Humans; Male; Middle Aged; N | 2013 |
Blistering eruption on the leg of an adult.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Blister; Ciprofloxacin; Dermatitis Herpetiformis; D | 2011 |
Bullous hemorrhagic myringitis.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Blister; Ciprofloxacin; Dexa | 2013 |
Pharmacokinetics of intravenously administered ciprofloxacin.
Topics: Adult; Blister; Body Fluids; Ciprofloxacin; Half-Life; Humans; Injections, Intravenous; Kinetics; Ma | 1984 |
Pharmacokinetics and tissue penetration of ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Blister; Body Fluids; Ciprofloxacin; Half-Life; Humans; Kinetics; Male | 1983 |
Fixed drug eruption induced by ofloxacin.
Topics: Anti-Infective Agents; Blister; Ciprofloxacin; Drug Eruptions; Erythema; Female; Foot Dermatoses; Ha | 1996 |
Evaluation of free tissue concentrations of fleroxacin after oral administration.
Topics: Administration, Oral; Adult; Blister; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxaci | 1990 |
Tissue penetration of ciprofloxacin after single and multiple doses.
Topics: Absorption; Adult; Blister; Ciprofloxacin; Female; Humans; Kinetics; Male; Quinolines; Saliva | 1986 |
Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Blister; Ciprofloxacin; Exudates and Transudates | 1987 |
Tissue penetration and metabolism of ciprofloxacin.
Topics: Administration, Oral; Adult; Aged; Biological Availability; Blister; Body Fluids; Ciprofloxacin; Hum | 1987 |
Pharmacokinetics of ciprofloxacin in peripheral lymph and skin blisters.
Topics: Adult; Blister; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Half-Life; Humans; Kine | 1986 |